Short answer · Medically reviewed summary · Last updated: 2026-04-07
Acromegaly is a rare hormonal disorder primarily caused by excess growth hormone (GH) production, and it is most commonly referred to by this name in modern clinical practice. While synonyms like Marie's disease or pituitary gigantism (when occurring before epiphyseal closure) are historically significant, Acromegaly remains the standardized term used in international medical classifications and patient support networks like DiseaseMaps. Why does Acromegaly have multiple names and historical designations? In medical literature, Acromegaly has been described under various terms based on the age of onset and the historical era of the observation.
Acromegaly is a rare hormonal disorder primarily caused by excess growth hormone (GH) production, and it is most commonly referred to by this name in modern clinical practice. While synonyms like Marie's disease or pituitary gigantism (when occurring before epiphyseal closure) are historically significant, Acromegaly remains the standardized term used in international medical classifications and patient support networks like DiseaseMaps.
In medical literature, Acromegaly has been described under various terms based on the age of onset and the historical era of the observation. The term "acromegaly" itself is derived from the Greek words akron (extremity) and megalos (great). Historically, you may find the condition referred to as "Marie's disease" in older texts, named after Pierre Marie, who provided the first detailed clinical description of the condition in 1886. Because the underlying pathology is an excess of growth hormone, it is sometimes colloquially linked to "pituitary hyperfunction" or "pituitary tumor syndrome." Understanding these varied terms is essential when researching older medical records or accessing international clinical archives.
Standardized medical systems utilize specific codes to ensure consistency in diagnosis and research. In the International Classification of Diseases (ICD-10 and ICD-11), Acromegaly is categorized under endocrine, nutritional, and metabolic diseases. The Online Mendelian Inheritance in Man (OMIM) database tracks the condition primarily through its genetic associations, such as those related to multiple endocrine neoplasia. Orphanet, the reference portal for rare diseases, uses the identifier ORPHA:1580 for Acromegaly. These official classifications help ensure that clinicians and researchers worldwide are referring to the same clinical entity when discussing patient care and experimental treatments.
The terminology often changes based on whether the excess growth hormone occurs before or after the closure of the growth plates (epiphyseal plates) in the bones. Medical professionals distinguish between these two presentations to guide treatment protocols:
Today, Acromegaly is the universally accepted clinical term. While some older literature might use descriptive names based on physical appearance, such as "hyperpituitarism," these are considered imprecise in modern endocrinology. Using the term Acromegaly ensures clear communication between specialists, radiologists, and surgeons. For the 112 members of our DiseaseMaps community living with this condition, using the standardized name helps in finding accurate resources, clinical trials, and peer support groups without the confusion of outdated nomenclature.
Medical Disclaimer: This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment; always seek the guidance of your physician with any questions regarding a medical condition.